Munalea 20 (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredient in Munalea 20, is a combined oral contraceptive presented as a tablet for oral use. It works by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining to prevent pregnancy in women of reproductive age.

GNH USA supplies Munalea 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, with established quality‑assurance processes and regulatory compliance across EU and other markets, and ensuring product integrity from manufacturing to delivery through rigorous testing.

Munalea 20, a combined oral contraceptive, is indicated for hormonal contraception in women.

Contraception: prevention of pregnancy in women of reproductive age. Acne management: reduction of inflammatory acne lesions when prescribed for dermatological benefit. Dysmenorrhea treatment: relief of painful menstrual cramps associated with ovulatory cycles.

Munalea 20 may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort of the breasts. - Irregular bleeding: spotting or changes in menstrual flow.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Hypertensive disorders: new‑onset or worsening high blood pressure. - Liver dysfunction: cholestatic jaundice or hepatic adenoma.

Before prescribing Munalea 20, clinicians should evaluate individual risk factors and counsel patients on safe use. - Assess thrombotic risk: review personal and family history of clotting disorders. - Screen for hypertension: monitor blood pressure prior to initiation. - Avoid smoking: especially in women over 35 years of age. - Consider hepatic function: adjust use in liver disease. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Munalea 20 can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Rifampin and other strong CYP3A4 inducers: can markedly decrease hormone levels. - Antiretroviral protease inhibitors (e.g., ritonavir): may increase hormone concentrations leading to adverse effects.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone levels, monitor for side effects. - St. John’s wort: may modestly reduce effectiveness, advise backup contraception. - Selective serotonin reuptake inhibitors: may increase risk of bleeding, observe.